Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOSTONE: Hydrochlorothiazide for Prevention of Recurrent Nephrolithiasis
NCT03057431Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Mar 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrochlorothiazide in nephrolithiasis, sponsored by Insel Gruppe. Started Mar 2017; status: completed.
02
Drugs
hydrochlorothiazide
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT03057431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057431.